AAAAAA
Results:
1-19
|
Results: 19
Authors:
Karlowsky, JA
Jones, ME
Thornsberry, C
Critchley, I
Kelly, LJ
Sahm, DF
Citation: Ja. Karlowsky et al., Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999, INT J ANT A, 18(2), 2001, pp. 121-127
Authors:
Karlowsky, JA
Nealy, L
Sahm, DF
Thornsberry, C
Jones, ME
Citation: Ja. Karlowsky et al., Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America, J CLIN MICR, 39(7), 2001, pp. 2748-2749
Authors:
McDermott, PF
Barry, AL
Jones, RN
Stein, GE
Thornsberry, C
Wu, CC
Walker, RD
Citation: Pf. Mcdermott et al., Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: Quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole, J CLIN MICR, 39(12), 2001, pp. 4283-4287
Authors:
Thornsberry, C
Karlowsky, JA
Sahm, DF
Citation: C. Thornsberry et al., Levofloxacin-resistant Streptococcus pneumoniae: Second look, ANTIM AG CH, 45(7), 2001, pp. 2183-2183
Authors:
Sahm, DF
Thornsberry, C
Mayfield, DC
Jones, ME
Karlowsky, JA
Citation: Df. Sahm et al., Multidrug-resistant urinary tract isolates of Escherichia coli prevalence and patient demographics in the United States in 2000, ANTIM AG CH, 45(5), 2001, pp. 1402-1406
Authors:
Sahm, DF
Karlowsky, JA
Kelly, LJ
Critchley, IA
Jones, ME
Thornsberry, C
Mauriz, Y
Kahn, J
Citation: Df. Sahm et al., Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis, ANTIM AG CH, 45(4), 2001, pp. 1037-1042
Authors:
Sahm, DF
Critchley, IA
Kelly, LJ
Karlowsky, JA
Mayfield, DC
Thornsberry, C
Mauriz, YR
Kahn, J
Citation: Df. Sahm et al., Evaluation of current activities of fluoroquinolones against gram-negativebacilli using centralized in vitro testing and electronic surveillance, ANTIM AG CH, 45(1), 2001, pp. 267-274
Authors:
Critchley, IA
Thornsberry, C
Piazza, G
Jones, M
Hickey, ML
Barth, AL
Mendes, C
Rossi, FF
Sader, HS
Teixeira, LM
Sahm, DF
Citation: Ia. Critchley et al., Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98, CL MICRO IN, 6(4), 2000, pp. 178-184
Authors:
Jones, ME
Staples, AM
Critchley, I
Thornsberry, C
Heinze, P
Engler, HD
Sahm, DF
Citation: Me. Jones et al., Benchmarking the in vitro activity of moxifloxacin against recent isolatesof Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study, DIAG MICR I, 37(3), 2000, pp. 203-211
Authors:
Sahm, DF
Jones, ME
Hickey, ML
Diakun, DR
Mani, SV
Thornsberry, C
Citation: Df. Sahm et al., Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998, J ANTIMICRO, 45(4), 2000, pp. 457-466
Authors:
Sahm, DF
Peterson, DE
Critchley, IA
Thornsberry, C
Citation: Df. Sahm et al., Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States, ANTIM AG CH, 44(9), 2000, pp. 2521-2524
Authors:
Jones, ME
Sahm, DF
Martin, N
Scheuring, S
Heisig, P
Thornsberry, C
Kohrer, K
Schmitz, FJ
Citation: Me. Jones et al., Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates ofStreptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the1997-1998 respiratory season, ANTIM AG CH, 44(2), 2000, pp. 462-466
Authors:
Jones, ME
Staples, AM
Critchley, I
Thornsberry, C
Heinze, P
Engler, HD
Sahm, DF
Citation: Me. Jones et al., Benchmarking the in vitro activities of moxifloxacin and comparator agentsagainst recent respiratory isolates from 377 medical centers throughout the United States, ANTIM AG CH, 44(10), 2000, pp. 2645-2652
Authors:
Thornsberry, C
Sahm, DF
Citation: C. Thornsberry et Df. Sahm, Antimicrobial resistance in respiratory tract pathogens: Results of an international surveillance study, CHEMOTHERA, 46, 2000, pp. 15-23
Authors:
Thornsberry, C
Jones, ME
Hickey, ML
Mauriz, Y
Kahn, J
Sahm, DF
Citation: C. Thornsberry et al., Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998, J ANTIMICRO, 44(6), 1999, pp. 749-759
Authors:
Jones, ME
Thornsberry, C
Livermore, DM
Sahm, DF
Citation: Me. Jones et al., Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network, J ANTIMICRO, 43(3), 1999, pp. 429-431
Authors:
Ge, YG
MacDonald, DL
Holroyd, KJ
Thornsberry, C
Wexler, H
Zasloff, M
Citation: Yg. Ge et al., In vitro antibacterial properties of pexiganan, an analog of magainin, ANTIM AG CH, 43(4), 1999, pp. 782-788
Authors:
Thornsberry, C
Ogilvie, PT
Holley, HP
Sahm, DF
Citation: C. Thornsberry et al., Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective US study, ANTIM AG CH, 43(11), 1999, pp. 2612-2623
Authors:
Thornsberry, C
Ogilvie, PT
Holley, HP
Sahm, DF
Citation: C. Thornsberry et al., In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: Correlation with penicillin resistance, CLIN THER, 20(6), 1998, pp. 1179-1190
Risultati:
1-19
|